Device Sectors
CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer
June 21, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsMISSISSAUGA, Ontario , June 21 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Careâ„¢ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for...
Cardiovascular Devices Market Outlook June Update by ReportsandReports
June 21, 2010 4:37 am | by Bio-Medicine.Org | News | CommentsDALLAS , June 21, 2010 /- ReportsandReports announces it Will Carry Cardiovascular Devices Market Outlook 2016 June reports in its store. Netherlands Cardiovascular Devices Market Outlook to 2016 ( http://www.reportsandreports.com/market-reports/netherlands-cardiovascul......
California Cryobank Welcomes New Director of Quality/Regulatory Affairs
June 21, 2010 4:37 am | by Bio-Medicine.Org | News | CommentsLOS ANGELES , June 21 /- California Cryobank (CCB), a worldwide leader in biotechnology services, is proud to announce the recent hiring of Rama Tyagi as the company's Director of Quality/Regulatory Affairs. Tyagi's hiring into the newly created position echoes CCB's ongoing commitment to...
Boston Scientific Expands PolarCath® Peripheral Dilatation System With New Balloon Sizes
June 21, 2010 4:36 am | by Boston Scientific | News | CommentsLonger balloons provide physicians more options for treating peripheral artery disease
Medco and Celesio Announce Pan-European Joint Venture to Enhance Quality of Clinical Care and Reduce Overall Healthcare Costs
June 21, 2010 1:34 am | by Bio-Medicine.Org | News | CommentsBERLIN , June 21 /- Medco Health Solutions, Inc. (NYSE: MHS ) and Celesio AG, two of the world's leading pharmacy-driven healthcare companies, today announced a joint venture with a long-term goal of improving patient health and helping to relieve the crushing financial burden on...
Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial
June 20, 2010 10:34 pm | by Bio-Medicine.Org | News | CommentsAHMEDABAD, India , June 21, 2010 /- Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique...
Drug Targets Lupus by Tricking Immune System
June 20, 2010 8:35 pm | by Massachusetts Institute of Technology | News | CommentsA new approach shows early promise in fighting the devastating disease.
Blood deficiencies are strong predictors of poor outcome
June 19, 2010 2:33 am | by EurekAlert | News | Comments(European League Against Rheumatism) For health care professionals diagnosing primary Sjogren's Syndrome (pSS, an autoimmune disorder in which immune cells attack and destroy moisture-producing glands), the incidence of blood based deficiencies is the strongest predictor of a poor...
UPDATE: Congress set to restore Medicare reimbursement next week
June 18, 2010 4:36 pm | by Mass Device | News | CommentsCongress is set to restore Medicare reimbursement for physicians next week, after a 21 percent cut went into effect June 18. Congress is set to restore Medicare reimbursement rates for physicians next week, meaning a de facto 2.2 percent pay raise, after a 21 percent cut went...
Delcath CEO Hobbs takes top spot on Capella's board
June 18, 2010 4:36 pm | by Mass Device | News | CommentsEamonn Hobbs, CEO of Delcath Systems, is tapped to be Irish stent maker Capella Inc.'s chairman of the board. Eamonn Hobbs took over as board chairman for Irish stent-maker Capella Inc. Hobbs is CEO of Delcath Systems Inc. (NSDQ:DCTH), a New York-based manufacturer of...
CytoPherx drums up $11.7 million for dialysis development
June 18, 2010 4:35 pm | by Mass Device | News | CommentsCytoPherx Inc. raises $11.7 million in equity, debt and options to develop a device that filters the blood of kidney-disease patients. By Brandon Glenn CytoPherx Inc. raised $11.7 million for the development of a device that filters the blood of kidney-disease patients. The Ann...
Coffee May Protect Against Head and Neck Cancers
June 18, 2010 4:34 pm | by AACR | News | CommentsThe embargo has been lifted on the AACR press release: “Coffee May Protect Against Head and Neck Cancers,†due to a violation by Drug Discovery and Development and the Sci-Tech Heretic blog. Reporters may post their stories effective immediately. • Caffeinated coffee protected against...
Sinovac Schedules 2010 Annual Meeting of Shareholders
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsBEIJING , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China , announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held...
Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO , June 18 /- Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City . The focus represents a growing interest and validation of how PEM can play an...
St. Jude Medical wins another CE Mark for cardiac ablation device
June 18, 2010 8:35 am | by Mass Device | News | CommentsSt. Jude Medical Inc. won another CE Mark from the European Union for a cardiac ablation device, this time for its cryogenic Therapy Cool Flex catheter. By Brandon Glenn St. Jude Medical Inc. (NYSE:STJ) won CE Mark approval in the European Union for a cryogenic cardiac ablation...
Zoll wins three-year AED contract in U.K.
June 18, 2010 8:35 am | by Mass Device | News | CommentsZoll Medical Corp. wins a three-year contract with Britain's national heart charity, the British Heart Foundation, to be its exclusive supplier of automated external defibrillators. Zoll Medical Corp. (NSDQ:ZOLL) landed a lucrative deal as the British Heart Foundation's...
Mylan Receives Approval for Generic Version of Zocor® Tablets
June 18, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH , June 18 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg,...
Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
June 18, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsROCKVILLE, Md. , June 18 /- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi , President and Chief Executive Officer, will be presenting at the Phacilitate Vaccine Forum Barcelona 2010 conference on June 21 and June 22, 2010 at The...
Medicare reimbursement cuts take effect
June 18, 2010 5:37 am | by Mass Device | News | CommentsStarting today, doctors face a 21 percent cut in Medicare reimbursement rates, after a Senate vote late June 17 to enact cuts mandated by sustainable growth rate legislation. The U.S. Senate voted late June 17 not to block a 21 percent reduction in Medicare reimbursement rates,...
MADIT-CRT Trial Data Show Women Received Greater Benefit From CRT-Ds Than Men
June 18, 2010 4:34 am | by Boston Scientific | News | CommentsNATICK, Mass. and NICE, France, June 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced results from a sub-analysis of the MADIT-CRT trial data that showed women received a greater clinical
Vitamin D deficiency confirmed as common across a range of rheumatic conditions
June 18, 2010 4:33 am | by EurekAlert | News | Comments(European League Against Rheumatism) Two separate studies have shown that vitamin D deficiency is common in patients with a range of rheumatic diseases, with over half of all patients having below the "normal" healthy levels of vitamin D (48-145 nmol/L) in their bodies. A further...
TGen partner, PBS-Bio, makes first breakthrough drug analysis
June 18, 2010 12:33 am | by EurekAlert | News | Comments(The Translational Genomics Research Institute) Predictive Biomarker Sciences Inc. has completed its first drug analysis, enabling Canadian biotech company PharmaGap Inc. to significantly advance a potentially significant anti-cancer medication.
Women who consume large amounts of tea have increased risk of rheumatoid arthritis
June 18, 2010 12:33 am | by EurekAlert | News | Comments(European League Against Rheumatism) Women who drink tea have an increased risk of developing rheumatoid arthritis (RA) compared with those who drink none (p=0.04), according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in...
Partners grieve rheumatoid arthritis diagnosis as much as patients
June 18, 2010 12:33 am | by EurekAlert | News | Comments(European League Against Rheumatism) Partners of patients newly diagnosed with rheumatoid arthritis are equally emotionally affected by the diagnosis and go through the same grieving process as the patients themselves, according to the results of a study presented today at EULAR...
Taking a stab at a career in medicine
June 17, 2010 3:37 pm | by Arizona State University | News | CommentsArizona high school students interested in pursuing careers in medicine, nursing, health care or veterinary medicine participated in a summer medical camp at ASU.read more
